Potential Hazards of Antifibrinolytic Treatment in Subarachnoid Haemorrhage

Please copy the URL and add it into your RSS Feed Reader.

Facebook Linkedin Weibo

Thromb Haemost 1980; 44(03): 170
DOI: 10.1055/s-0038-1650116

Letter of the Editor

Schattauer GmbH Stuttgart

Anna Levati

^*Department of Anaesthetics, Ospedale Niguarda, Milan, Italy

,

Claudio Minella

^*Department of Anaesthetics, Ospedale Niguarda, Milan, Italy

,

Mario Luisa Farina

^*Department of Anaesthetics, Ospedale Niguarda, Milan, Italy

,

Vincenzo D'Angelo

^**Department of Neurosurgery, Ospedale Niguarda, Milan, Italy

Further Information

Publication History

Received 31 July 1980

Accepted 16 October 1980

Publication Date:
13 July 2018 (online)

References
1 Fodstad H, Liliequist B, Schannong M, Thulin C. Tranexamic acid in the preoperative management of ruptured intracranial aneurysms. Surg Neurol 1978; 10: 9-15

MissingFormLabel
PubMed Search in Google Scholar
2 Jotkowitz S. Epsilon aminocaproic acid and possible pulmonary emboli. New Engl J Med 1974; 290: 861

MissingFormLabel
PubMed Search in Google Scholar
3 Farina ML, Levati A, Paino R. Myocardial infarction during antifibrinolytic treatment of subarachnoid haemorrhage. Thromb Haemostas 1979; 42: 1347-1348

MissingFormLabel
PubMed Search in Google Scholar